GlaxoSmithKline (GSK) Q2: Core EPS 26.4 pence. Sales -3.9% to £6.46B vs. consensus of £6.65B....

|About: GlaxoSmithKline (GSK)|By:, SA News Editor
GlaxoSmithKline (GSK) Q2: Core EPS 26.4 pence. Sales -3.9% to £6.46B vs. consensus of £6.65B. Net profit +13% to £1.25B vs. consensus of £1.34B. Increases dividend by 6% to 17 pence. Shares -0.85%. (PR)